Senior Medical Science Liaison
Gilead SciencesFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Employment Type: Full-time
Moderna is seeking a highly motivated Field Medical Advisor to join our growing team in Germany. This role is crucial for establishing and nurturing relationships with the medical and healthcare community, including healthcare practitioners, policy makers, payers, patient groups, and healthcare administrators. The Field Medical Advisor will serve as a key liaison, sharing the scientific advancements of Moderna's mRNA platform to improve patient outcomes. This position offers a unique opportunity to be part of a pioneering team revolutionizing medicine through mRNA technology, with a diverse pipeline of development programs across various diseases. You will contribute to global health initiatives within a continually growing organization, working alongside exceptional colleagues and strategic partners worldwide.
Moderna is solidifying its presence in Germany, a country renowned for its leadership in science, research, and pharmaceutical innovation. As part of our growing operations, we are dedicated to advancing the development and delivery of mRNA-based medicines and vaccines. We are seeking exceptional talent to join us in transforming medicine and making a meaningful impact on global health. Moderna's commitment to advancing the technological frontier of mRNA medicines ensures a challenging and rewarding career experience with the potential to make a significant impact on patients' lives worldwide.
Develops mRNA-based medicines for health
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.